We have shown that mitochondria- and NOX4-derived ROS drive NFE2L2 antioxidant defense in hepatocytes to limit the oxidative damage of macromolecules, the development of insulin resistance, and the progression to NASH and fibrosis. The gene discussed is NOX4; the disease is metabolic dysfunction-associated steatohepatitis.